|
Special Diversified Opportunities Inc. is a biotechnology company based in the state of Delaware. The company provides medical products including antigens and antibodies.〔(【引用サイトリンク】title=Special Diversified Opportunities Inc: OTCMKTS:SDOI quotes & news - Google Finance )〕 The company includes is divided into Life Science Segment and Kit Product Segment.〔(【引用サイトリンク】title=SDOI Key Statistics - Special Diversified Opportunities Inc. Financial Ratios - MarketWatch )〕 ==History== In October 1990, the company was founded with the initial name of Strategic Diagnostics. In 1996, the company completed the acquisition of Ohmicron Environmental, EnSys Environmental, and it became publicly held. In 1999, the company completed the acquisition of HTI BioProducts and Atlantic Antibodies OEM. In 2001, the company completed the acquisition of AZUR Environmental. In 2002, the company completed the acquisition of MCI assets. In 2010, Strategic Diagnostics was changed name to Special Diversified Opportunities Inc. In 2011, the company completed the sale of Water Quality assets. In 2012, the company completed the sale of s Food Safety and GMO businesses. In 2013, the company completed the sale of Life Science Assets. In 2013, the company announced the beginning of its common stock trading on the OTCQB Market under the ticker symbol “SDIX”. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Special Diversified Opportunities」の詳細全文を読む スポンサード リンク
|